73
Participants
Start Date
January 24, 2024
Primary Completion Date
January 31, 2025
Study Completion Date
January 31, 2025
Cerebiome
Evaluate the effect of oral intake of a probiotic agent on plasma inflammatory markers, gut bacterial profile and depressive state in a subgroup of target patients versus a subgroup treated with placebo
Placebo
Placebo effect: Evaluate the effect of oral intake of a placebo, on clinical and plasma inflammatory markers, in a subgroup treated with placebo, in combination with conventional treatment for 12 weeks
Saint-Joseph University, Beirut
Lallemand Health Solutions, Canada
UNKNOWN
St Joseph University, Beirut, Lebanon
OTHER